CN1935194A - 一种治疗肾病的中药组合物及其应用 - Google Patents
一种治疗肾病的中药组合物及其应用 Download PDFInfo
- Publication number
- CN1935194A CN1935194A CNA2006100522401A CN200610052240A CN1935194A CN 1935194 A CN1935194 A CN 1935194A CN A2006100522401 A CNA2006100522401 A CN A2006100522401A CN 200610052240 A CN200610052240 A CN 200610052240A CN 1935194 A CN1935194 A CN 1935194A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- flos chrysanthemi
- appropriate
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 241000232901 Nephroma Species 0.000 title 1
- 208000025351 nephroma Diseases 0.000 title 1
- 201000008383 nephritis Diseases 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 230000000694 effects Effects 0.000 claims description 19
- 241000628997 Flos Species 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 235000008597 Diospyros kaki Nutrition 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 13
- 239000003826 tablet Substances 0.000 claims description 12
- 239000000654 additive Substances 0.000 claims description 11
- 239000008187 granular material Substances 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 241000545442 Radix Species 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000007938 effervescent tablet Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 239000000890 drug combination Substances 0.000 claims 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims 1
- 238000005457 optimization Methods 0.000 claims 1
- 241000167550 Centella Species 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 235000011511 Diospyros Nutrition 0.000 abstract 1
- 244000202566 Hydrocotyle vulgaris Species 0.000 abstract 1
- 235000015916 Hydrocotyle vulgaris Nutrition 0.000 abstract 1
- 241001127637 Plantago Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000001154 acute effect Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 7
- 206010001580 Albuminuria Diseases 0.000 description 6
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 6
- 208000006750 hematuria Diseases 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 5
- 206010018364 Glomerulonephritis Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 208000017169 kidney disease Diseases 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000022461 Glomerular disease Diseases 0.000 description 1
- 206010018366 Glomerulonephritis acute Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 例数 | 治疗前(%) | 治疗后7天(%) | 治疗后14天(%) |
对照组 | 14 | 100 | 85 | 60* |
治疗组 | 14 | 100 | 30** | 13** |
组别 | 例数 | 治疗前 | 治疗后7天 | 治疗后14天 |
对照组 | 14 | 242.15±97.86 | 232.12±101.89 | 177.18±74.58* |
治疗组 | 14 | 257.95±110.29 | 190.38±92.75* | 106.81±68.97 |
组别 | 例数 | 治疗前 | 治疗后7天 | 治疗后14天 |
对照组 | 14 | 9.25±2.79 | 8.14±3.68 | 7.49±2.90* |
治疗组 | 14 | 9.98±3.40 | 7.12±2.95* | 6.03±3.15* |
临床 | 基本治愈 | 有效 | 无效 | 总有效率(%) |
治疗组 | 10 | 3 | 1 | 92.86 |
对照组 | 8 | 3 | 3 | 78.57 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100522401A CN1935194B (zh) | 2006-06-30 | 2006-06-30 | 一种治疗肾病的中药组合物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100522401A CN1935194B (zh) | 2006-06-30 | 2006-06-30 | 一种治疗肾病的中药组合物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1935194A true CN1935194A (zh) | 2007-03-28 |
CN1935194B CN1935194B (zh) | 2011-11-09 |
Family
ID=37953054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100522401A Expired - Fee Related CN1935194B (zh) | 2006-06-30 | 2006-06-30 | 一种治疗肾病的中药组合物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1935194B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102028897A (zh) * | 2010-12-08 | 2011-04-27 | 山西医科大学第一医院 | 一种治疗肾小球源性血尿的中成药及其制备方法 |
CN102988815A (zh) * | 2012-12-27 | 2013-03-27 | 苗娥 | 一种可有效治疗肾炎的保健药茶及其制备方法 |
CN106138166A (zh) * | 2016-07-26 | 2016-11-23 | 北京致成生物医学科技有限公司 | 一种柿叶药饮在治疗尿毒症中的应用 |
CN106176891A (zh) * | 2016-07-06 | 2016-12-07 | 北京致成生物医学科技有限公司 | 一种柿叶药饮及其制备方法和应用 |
CN106234896A (zh) * | 2016-08-05 | 2016-12-21 | 北京致成生物医学科技有限公司 | 一种治疗肾病的保健饮品及其制备方法 |
CN110882306A (zh) * | 2019-12-26 | 2020-03-17 | 三穗县人民医院 | 一种治疗急性肾炎的药物及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1159933A (zh) * | 1996-11-07 | 1997-09-24 | 昆明医学院第一附属医院 | 利通口服液及其制备方法 |
-
2006
- 2006-06-30 CN CN2006100522401A patent/CN1935194B/zh not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102028897A (zh) * | 2010-12-08 | 2011-04-27 | 山西医科大学第一医院 | 一种治疗肾小球源性血尿的中成药及其制备方法 |
CN102988815A (zh) * | 2012-12-27 | 2013-03-27 | 苗娥 | 一种可有效治疗肾炎的保健药茶及其制备方法 |
CN102988815B (zh) * | 2012-12-27 | 2014-06-18 | 苗娥 | 一种可治疗肾炎的保健药茶及其制备方法 |
CN106176891A (zh) * | 2016-07-06 | 2016-12-07 | 北京致成生物医学科技有限公司 | 一种柿叶药饮及其制备方法和应用 |
CN106138166A (zh) * | 2016-07-26 | 2016-11-23 | 北京致成生物医学科技有限公司 | 一种柿叶药饮在治疗尿毒症中的应用 |
CN106234896A (zh) * | 2016-08-05 | 2016-12-21 | 北京致成生物医学科技有限公司 | 一种治疗肾病的保健饮品及其制备方法 |
CN110882306A (zh) * | 2019-12-26 | 2020-03-17 | 三穗县人民医院 | 一种治疗急性肾炎的药物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1935194B (zh) | 2011-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1935194B (zh) | 一种治疗肾病的中药组合物的制备方法 | |
JP2002154979A (ja) | I型アレルギー用医薬組成物およびその製造方法 | |
CN101461932B (zh) | 一种治疗小儿脾虚湿热腹泻的药物组合物及其制备方法 | |
CN1840092B (zh) | 一种摩罗颗粒及其制备方法 | |
CN102657736B (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法 | |
CN1814195B (zh) | 一种治疗月经病的中药组合物及其制备方法 | |
CN101983689B (zh) | 一种治疗前列腺炎的药物及其制备方法 | |
CN103705578B (zh) | 具有降血脂与抑制血糖升高作用的中药制剂及其制备方法 | |
CN110876772A (zh) | 一种具有保肝护肝功能的中药制剂的制备方法及应用 | |
CN1814193B (zh) | 一种治疗肾炎水肿的中药组合物及其制备方法 | |
CN1814217B (zh) | 一种治疗风湿关节炎的中药组合物及其制备方法 | |
CN104547696A (zh) | 一种治疗小儿肾病综合征的中药组合物及其应用 | |
CN1814176B (zh) | 一种治疗肺结核病的中药组合物及其制备方法 | |
CN1943718B (zh) | 一种中药组合物及其制备方法 | |
CN101468056B (zh) | 一种治疗肠炎腹泻红白痢疾的中药制剂 | |
CN1899574A (zh) | 一种防治肝癌的中药组合物及其应用 | |
CN1814250B (zh) | 一种治疗肝硬化腹水的中药组合物及其制备方法 | |
CN1830482B (zh) | 一种治疗小儿肺炎的中药组合物与应用 | |
CN1899425B (zh) | 一种治疗月经病的中药组合物 | |
CN101700323B (zh) | 一种防治肝癌的药物组合物 | |
CN115337363B (zh) | 一种治疗肾炎血尿的中药组合物及其制备方法和应用 | |
CN109091645A (zh) | 一种具有治疗hiv病毒的药物组合物 | |
CN1899416A (zh) | 一种治疗风湿病的中药组合物及其应用 | |
CN102488851A (zh) | 治疗反复发作生殖器疱疹的药物及其制备方法 | |
CN100998785B (zh) | 一种治疗胃肠疾病的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090109 Address after: Zhejiang city of Ningbo province Yinzhou District Yinxian Avenue East Zhejiang Pharmaceutical College No. 888 post encoding: 315100 Applicant after: Yang Xiong Zhi Co-applicant after: Yang Yijie Address before: 21, 4 floor, 293 South Rainbow Road, Jiangdong District, Zhejiang, Ningbo, China: 315040 Applicant before: Yang Yijie |
|
ASS | Succession or assignment of patent right |
Owner name: YANG XIONGZHI Free format text: FORMER OWNER: YANG YIKAI Effective date: 20090109 |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: YANG YIKAI Owner name: NINGBO YUANZHI BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: YANG XIONGZHI Effective date: 20110927 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110927 Address after: 315100, room 10, building 68, Lane 402, Tai Mo Road, Ningbo, Zhejiang, Yinzhou District Applicant after: Ningbo Yuanzhi Biotechnology Co., Ltd. Address before: 315100 Zhejiang city of Ningbo province Yinzhou District County Road No. 888 east section of Zhejiang Pharmaceutical College Applicant before: Yang Xiongzhi Co-applicant before: Yang Yijie |
|
CI01 | Correction of invention patent gazette |
Correction item: The patent holder|the address of the patent holder Correct: Ningbo Yuanzhi Biotechnology Co., Ltd.|315100, room 10, building 68, Lane 402, Tai Mo Road, Ningbo, Zhejiang, Yinzhou District False: Yang Xiongzhi Yang Yikai|315100 Zhejiang city of Ningbo province Yinzhou District County Road No. 888 east section of Zhejiang Pharmaceutical College Number: 45 Volume: 27 |
|
CI02 | Correction of invention patent application |
Correction item: The patent holder; the address of the patent holder Correct: Ningbo Yuanzhi Biotechnology Co., Ltd.|315100, room 10, building 68, Lane 402, Tai Mo Road, Ningbo, Zhejiang, Yinzhou District False: Yang Xiongzhi Yang Yikai|315100 Zhejiang city of Ningbo province Yinzhou District County Road No. 888 east section of Zhejiang Pharmaceutical College Number: 45 Page: The title page Volume: 27 |
|
ERR | Gazette correction |
Free format text: CORRECT: PATENTEE PATENTEE ADDRESS; FROM: YANG XIONGZHI YANG YIKAI;315100 ZHEJIANG PHARMACEUTICAL COLLEGE, NO.888, EAST SECTION, YINXIAN AVENUE, YINZHOU DISTRICT, NINGBO CITY, ZHEJIANG PROVINCE TO: NINGBO YUANZHI BIOTECHNOLOGY CO., LTD.;315100 ROOM 402, BUILDING 10, LANE 68, TAIYU ROAD, YINZHOU DISTRICT, NINGBO CITY, ZHEJIANG PROVINCE |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111109 Termination date: 20140630 |
|
EXPY | Termination of patent right or utility model |